Literature DB >> 18822105

Successful allogeneic unrelated bone marrow transplantation using reduced-intensity conditioning for the treatment of X-linked adrenoleukodystrophy in a one-yr-old boy.

Kazumi Okamura1, Tsutomu Watanabe, Toshihiro Onishi, Hiroyoshi Watanabe, Emiko Fujii, Kenji Mori, Junko Matsuda.   

Abstract

The childhood cerebral form of X-linked ALD is a demyelinating disorder of the central nervous system, which rapidly leads to total disability and death. Allogeneic stem cell transplantation benefits patients who show early evidence of the demyelination. We report here a one-yr-old boy with ALD who received HLA-matched unrelated BMT in an early stage of the disease after careful planning and observation since his birth. BMT was performed when MRI began to show slight signal intensity changes in the white matter of the brain. Pretransplant conditioning consisted of fludarabine, l-PAM and TBI (2 Gy). GVHD prophylaxis consisted of cyclosporine A and short-course methotrexate. The patient showed an uneventful BMT course with fast and stable engraftment. Following BMT, the plasma levels of VLCFA decreased gradually and MRI changes improved. The patient did not have any evidence of further neurological deterioration 22 months following the transplant. Although this is still a short follow-up, it has been shown that BMT should be considered when a child has a biochemical diagnosis and MRI findings of ALD without any neurological signs. RIST should be considered as a pretransplant conditioning for ALD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18822105     DOI: 10.1111/j.1399-3046.2008.00962.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  7 in total

Review 1.  Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

Authors:  Jian-Ming Li; Cynthia R Giver; Ying Lu; Mohammad S Hossain; Mojtaba Akhtari; Edmund K Waller
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

Review 2.  Recent trends in mucopolysaccharidosis research.

Authors:  Hiroshi Kobayashi
Journal:  J Hum Genet       Date:  2018-11-19       Impact factor: 3.172

3.  MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines.

Authors:  Eric J Mallack; Bela R Turk; Helena Yan; Carrie Price; Michelle Demetres; Ann B Moser; Catherine Becker; Kim Hollandsworth; Laura Adang; Adeline Vanderver; Keith Van Haren; Maura Ruzhnikov; Joanne Kurtzberg; Gustavo Maegawa; Paul J Orchard; Troy C Lund; Gerald V Raymond; Molly Regelmann; Joseph J Orsini; Elisa Seeger; Stephan Kemp; Florian Eichler; Ali Fatemi
Journal:  J Inherit Metab Dis       Date:  2021-01-09       Impact factor: 4.982

4.  Allogeneic stem cell transplantation with reduced intensity conditioning for patients with adrenoleukodystrophy.

Authors:  Koji Kato; Ryo Maemura; Manabu Wakamatsu; Ayako Yamamori; Motoharu Hamada; Shinsuke Kataoka; Atsushi Narita; Shunsuke Miwata; Yuko Sekiya; Nozomu Kawashima; Kyogo Suzuki; Kotaro Narita; Sayoko Doisaki; Hideki Muramatsu; Hirotoshi Sakaguchi; Kimikazu Matsumoto; Yuka Koike; Osamu Onodera; Makiko Kaga; Nobuyuki Shimozawa; Nao Yoshida
Journal:  Mol Genet Metab Rep       Date:  2018-11-20

5.  Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation.

Authors:  Alex R Kemper; Jeffrey Brosco; Anne Marie Comeau; Nancy S Green; Scott D Grosse; Elizabeth Jones; Jennifer M Kwon; Wendy K K Lam; Jelili Ojodu; Lisa A Prosser; Susan Tanksley
Journal:  Genet Med       Date:  2016-06-23       Impact factor: 8.822

Review 6.  The role of microglia in human disease: therapeutic tool or target?

Authors:  Nathalie Cartier; Coral-Ann Lewis; Regan Zhang; Fabio M V Rossi
Journal:  Acta Neuropathol       Date:  2014-08-09       Impact factor: 17.088

7.  Murine iPSC-Derived Macrophages as a Tool for Disease Modeling of Hereditary Pulmonary Alveolar Proteinosis due to Csf2rb Deficiency.

Authors:  Adele Mucci; Jessica Kunkiel; Takuji Suzuki; Sebastian Brennig; Silke Glage; Mark P Kühnel; Mania Ackermann; Christine Happle; Alexandra Kuhn; Axel Schambach; Bruce C Trapnell; Gesine Hansen; Thomas Moritz; Nico Lachmann
Journal:  Stem Cell Reports       Date:  2016-07-21       Impact factor: 7.765

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.